Improving Our Value by Improving Our Care

Diplomat (NYSE: DPLO) is the nation’s largest independent provider of specialty pharmacy and infusion services. Diplomat helps people with complex and chronic health conditions in all 50 states, partnering with payers, providers, hospitals, manufacturers, and more. Rooted in deep specialty-pharmacy expertise, Diplomat’s innovative service model unites complementary brands to anticipate market needs, create shareholder value, and drive better patient outcomes. TEST

Date Filing Filing Description Download
December 21, 2017 8-K Current report filing
November 22, 2017 4 Statement of Changes in Beneficial Ownership
November 20, 2017 4 Statement of Changes in Beneficial Ownership


+0.01 +0.25% $ 3.99 Volume: 481,394 Common Stock | 20 minute delay January 21, 2020

Investor Contact

Terri Anne Powers,
Vice President, Investor Relations
Diplomat Pharmacy Inc.
Phone: 312.889.5244

Email Now